Current Gene Therapy
Title: Editorial [Hot Topic: Gene Therapy for Cancer (Guest Editor: Maria G. Castro)]
Volume: 5 Issue: 6
Author(s): Maria G. Castro
Affiliation:
Export Options
About this article
Cite this article as:
Castro G. Maria, Editorial [Hot Topic: Gene Therapy for Cancer (Guest Editor: Maria G. Castro)], Current Gene Therapy 2005; 5 (6) . https://dx.doi.org/10.2174/156652305774964622
DOI https://dx.doi.org/10.2174/156652305774964622 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inhibition of Topoisomerase I by Anti-Cancer Drug Altered the Endometrial Cyclicity and Receptivity
Current Molecular Medicine Nanoparticulate Drug Delivery Systems for Treatment of Hepatocellular Carcinoma
Current Cancer Therapy Reviews Imaging of Integrins as Biomarkers for Tumor Angiogenesis
Current Pharmaceutical Design Mechanisms of Anorexia Cancer Cachexia Syndrome and Potential Benefits of Traditional Medicine and Natural Herbs
Current Pharmaceutical Biotechnology Neoadjuvant Strategies for Triple Negative Breast Cancer: ‘State-of-the-art’ and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Design, Synthesis and In Vitro Evaluation of 18β-Glycyrrhetinic Acid Derivatives for Anticancer Activity Against Human Breast Cancer Cell Line MCF-7
Current Medicinal Chemistry Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways
Current Stem Cell Research & Therapy Glyconanoparticles for Biomedical Applications
Combinatorial Chemistry & High Throughput Screening Polymer Particulates in Drug Delivery
Current Pharmaceutical Design A Review of Therapeutic Effects of Curcumin
Current Pharmaceutical Design Dual Drug Conjugate Loaded Nanoparticles for the Treatment of Cancer
Current Drug Delivery Natural Macromolecules with Protective and Antitumor Activity
Anti-Cancer Agents in Medicinal Chemistry From Raynaud’s Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach
Current Rheumatology Reviews Meet Our Editorial Board Member:
Current Drug Discovery Technologies Meet Our Editorial Board Member
Current Cancer Drug Targets A Mild and Convenient Semi-Synthesis of Docetaxel from 10-Deacetyl Baccatin III
Letters in Organic Chemistry Prediction of Disease-Related Genes Based on Hybrid Features
Current Proteomics Inhibition of Molecular Signaling in Huh-7 Cells by AM3: A Novel Chemotherapeutic Agent for Hepatocellular Carcinoma
Medicinal Chemistry Recent Progress on Antifungal Drug Development
Current Pharmaceutical Biotechnology Homocysteine and Folate Therapy in Dialysis Patients
Letters in Drug Design & Discovery